Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 465)
Posted On: 12/28/2022 11:20:21 AM
Post# of 154756
Posted By: KenChowder
Yes, I know we are not in the Covid business any more. But it could be that despite Amarex and despite the FDA and despite NP's incompetence (or whatever), the world will someday need Leron for... Covid. So just stick this into the Someday, Baby drawer:

Quote:
MEDSCAPE … Four [COVID-19] Omicron subvariants … will be the most common strains going from person to person this winter, new research predicts…. BQ.1, BQ1.1, XBB, and XBB.1 … [and they] are the most resistant to neutralizing antibodies, researcher Qian Wang, PhD, and colleagues report. This means you have no or "markedly reduced" protection against infection from [them], even if you've already had COVID-19 or are vaccinated and boosted multiple times, including with a bivalent vaccine. [And] all available monoclonal antibody treatments are mostly or completely ineffective against these subvariants.



Of course those available MABs do not include Leron....













(9)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site